[Management of dysfunctional bleeding as well as hyper- and polymenorrheas using high doses of ovulation inhibitors].
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D003276:Contraceptives, Oral / Q000008:administration & dosage*; D004357:Drug Synergism; D005260:Female; D006801:Humans; D008234:Lynestrenol / Q000008:administration & dosage / Q000009:adverse effects; D008595:Menorrhagia / Q000188:drug therapy; D008599:Menstruation Disturbances / Q000188:drug therapy*; D008656:Mestranol / Q000008:administration & dosage / Q000009:adverse effects; D008796:Metrorrhagia / Q000188:drug therapy; D008875:Middle Aged; D013997:Time Factors
D003276:Contraceptives, Oral; D008656:Mestranol; D008234:Lynestrenol
Behandlung dysfunktsoneller Blutungen sowie von Hyper- und Polymenorrhosen mt einem hoch dosierten Ovulationshemmer.